A carregar...

Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses

OBJECTIVE: Exposure‐response (E‐R) models were developed to provide a description of the time‐course of treatment effect for monthly and quarterly dosing regimens of fremanezumab. BACKGROUND: Fremanezumab is a monoclonal antibody for preventive treatment of episodic migraine (EM) and chronic migrain...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Headache
Main Authors: Fiedler‐Kelly, Jill, Passarell, Julie, Ludwig, Elizabeth, Levi, Micha, Cohen‐Barak, Orit
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7496732/
https://ncbi.nlm.nih.gov/pubmed/32445498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.13845
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!